Which type of immunity occurs when antibodies develop in response to a vaccine?
Solved
Show answers
More tips
- H Health and Medicine Understanding Pregnancy Tests: What You Need to Know?...
- H Health and Medicine What Makes a Man a Man?...
- C Computers and Internet How to Get Rid of Spam in ICQ?...
- A Art and Culture Who Said The Less We Love a Woman, the More She Likes Us ?...
- F Family and Home How to Get Rid of Your Neighbors?...
- S Society and Politics How Could Nobody Know About the Dead Mountaineers?...
- H Health and Medicine How to Cure Adenoids?...
- H Health and Medicine Why Wearing a Back Brace Can Be Beneficial During Back Strain?...
- S Sport When and Where Will the 2014 World Cup be Held?...
- C Computers and Internet How to Choose a Monitor?...
Answers on questions: Biology
- B Biology Sedimentary rocks are formed when sediments, smaller pieces of rock, gravel, sand, silt, or clay, are compacted and cemented together O True O False...
- B Biology Ecosystem services are real services, and they are discussed in terms of their monetary value, just like any other service that people need and purchase. Which of...
- B Biology will mark brainliest...
- B Biology Which of the following is not a phenotype?...
- B Biology In rabbits, black fur (B) is dominant to white (b), and long ears (E) are dominant toshort ears (e). What is the expected phenotypic ratio of the offspring ofa BBee...
- B Biology Correlational research allows the researcher to answer questions such as:...
- B Biology This is a example of ____...
- B Biology Gene regulation means A. The genes in some cells are different than the genes in other cells. B. only some specialized cells can become other specialized cells....
- B Biology I WILL MARK BRAINLIST Fill in the blanks with the correct words.The movement of molecules from an area of low concentration to an area of high concentration occurs...
- B Biology 100 POINTS: how is the coronavirus a social issue and who does it affect?...
Ответ:
Explanation:
Abstract
In 2014, West Africa confronted the most severe outbreak of Ebola virus disease (EVD) in history. At the onset of the outbreak—as now—there were no therapies approved by the U.S. Food and Drug Administration (FDA) for prevention of, post-exposure prophylaxis against, or treatment of EVD. As a result, the outbreak spurred interest in developing novel treatments, sparked calls to use experimental interventions in the field, and highlighted challenges to the standard approach to FDA approval of new drugs. Although the outbreak was geographically centered in West Africa, it showcased FDA's global role in drug development, approval, and access. FDA's response to EVD highlights the panoply of agency powers and demonstrates the flexibility of FDA's regulatory framework. This paper evaluates the strengths and weaknesses of FDA's response and makes policy recommendations regarding how FDA should respond to new and re-emerging public health threats. In particular, it argues that greater emphasis should be placed on drug development in interoutbreak periods and on assuring access to approved products. The current pandemic of Zika virus infection is but one example of an emerging health threat that will require FDA involvement in order to achieve a successful response.